GPX Medical in Media

We develop technology for improving the care and life quality of our most vulnerable patients – preterm born infants.

Inbjudan till presentation av bokslutskommuniké 2020 för GPX Medical

Pressmeddelande Lund, Sverige, 26 januari 2021 kl. 15:00 CEST GPX Medical AB (publ) bjuder in till presentation av bokslutskommuniké 2020 tisdagen den 16 februari kl. 10.00. Presentationen sker via videokonferens. Bokslutskommunikén kommer att publiceras kl. 09.00...

GPX Medical ökar takten mot marknad genom nyckelrekryteringar

Pressmeddelande GPX Medical förstärker organisationen med tre nyckelrekryteringar inför bolagets kommersialisering av sin unika patenterade produkt för kontinuerlig lungövervakning av för tidigt födda barn NEOLA®. Genom rekryteringarna tillförs bolaget kompetens...

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in GPX Medical

About GPX Medical

GPX Medical AB is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012